Skip to main content
All lobbying filings

VAN SCOYOC ASSOCIATES

Lobbying for MEMSEL, INC. · Scientific research & development company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · $20,000.00 income · posted Jan 19, 2026

Official filing document

 Bills named in this filing 4
  • HR 4016
    Department of Defense Appropriations Act, 2026
  • S 2572
    Department of Defense Appropriations Act, 2026
  • HR 8774
    Department of Defense Appropriations Act, 2025
  • S 4921
    Financing Lead Out of Water Act of 2022
 Lobbying activity 3
Budget/Appropriations

Monitor Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026

Defense

Monitor Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026

Health Issues

Monitor Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem